Economic evaluation of public-private mix for tuberculosis care and control, India. Part II. Cost and cost-effectiveness

International Journal of Tuberculosis and Lung Disease

Volumn 13, Issue 6, 2009, Pages 705-712

  Pantoja, Andrea ^a,d   Lonnroth K ^a   Lal, S S ^a   Chauhan, L S ^b   Uplekar, M ^a   Padma, M R ^b   Unnikrishnan, K P ^c   Rajesh, J ^c   Kumar, P ^c   Sahu, S ^a   Wares, F ^a   Floyd, K ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b GOVERNMENT OF INDIA   (India)

^c NATIONAL TUBERCULOSIS INSTITUTE   (India)

^d NONE   (Switzerland)

Author keywords

Cost effectiveness; India; Patient costs; Public private mix; Tuberculosis

Indexed keywords

ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; ECONOMIC EVALUATION; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INDIA; MAJOR CLINICAL STUDY; MEDICAL RECORD; PRIORITY JOURNAL; PRIVATE PRACTICE; PUBLIC HEALTH; TUBERCULOSIS; TUBERCULOSIS CONTROL; URBAN POPULATION;

ANTITUBERCULAR AGENTS; COMMUNICABLE DISEASE CONTROL; COSTS AND COST ANALYSIS; DIRECTLY OBSERVED THERAPY; HUMANS; INDIA; NATIONAL HEALTH PROGRAMS; PROGRAM EVALUATION; PUBLIC-PRIVATE SECTOR PARTNERSHIPS; QUESTIONNAIRES; TUBERCULOSIS;

EID: 67649224653     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Raviglione M C, Uplekar M W. WHO's new Stop TB Strategy. Lancet 2006; 367: 952-955.
2. World Health Organization. Stop TB Partnership and World Health Organization. The Global Plan to Stop TB, 2006-2015. Geneva, Switzerland: Stop TB Partnership, 2006.
3. World Health Organization. Global tuberculosis control: surveillance, planning, financing. WHO/HTM/TB/2008.393. Geneva, Switzetland: WHO, 2008.
4. World Health Organization. An expanded DOTS framework for effective tuberculosis control. Geneva, Switzerland: WHO, 2002: pp 1-20.
5. Ministry of Health and Family Welfare. TB India 2007. RNTCP status report. New Delhi, India: Central TB Division (CTD), Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India, 2007.
6. Murthy KJR, Firedern T R, Yazdani A, Hreshikesh P. Public- private partnership in tuberculosis control: experience in Hyderabad, India. Int J Tuberc Lung Dis 2001; 5: 354-359. (Pubitemid 32397586)
7. Floyd K, Arora V K, Murthy K J, et al. Cost and cost-effectiveness of PPM-DOTS for tuberculosis control: evidence from India. Bull World Health Organ 2006; 84: 437-445. (Pubitemid 43845443)
8. Dewan P K, Lal S S, Lönnroth K, et al. Improving tuberculosis control through public-private collaboration in India: literature review. BMJ 2006; 332: 574-578. (Pubitemid 44365755)
9. Ambe G, Lönnroth K, Dholakia Y, et al. Every provider counts: effect of a comprehensive public-private mix approach for TB control in a large metropolitan area in India. Int J Tuberc Lung Dis 2005; 9: 562-568. (Pubitemid 40646844)
10. Arora V K, Sarin R, Lönnroth K. Feasibility and effectiveness of a public-private mix project for improved TB control in Delhi, India. Int J Tuberc Lung Dis 2003; 7: 1131-1138. (Pubitemid 38004736)
11. Government of Karnataka, Department of Economic Affairs. Economic survey of Karnataka - economic situation 2003- 2004. Bangalore, Karnataka: Statistics GoKDoEa, 2004: pp 169-251.
12. Quy H T, Lönnroth K, Lan N T, Buu T N. Treatment results among tuberculosis patients treated by private lung specialists involved in a public-private mix project in Vietnam. Int J Tuberc Lung Dis 2003; 7: 1139-1146. (Pubitemid 38004737)
13. Uplekar M, Juvekar S, Morankar S, Rangan S, Nunn P. Tuberculosis patients and practitioners in private clinics in India. Int J Tuberc Lung Dis 1998; 2: 324-329. (Pubitemid 28168310)
14. Lönnroth K, Thuong L M, Lambregts K, Quy H T, Diwan V K. Private tuberculosis care provision associated with poor treatment outcome: comparative study of a semi-private lung clinic and the NTP in two urban districts in Ho Chi Minh City, Vietnam. Int J Tuberc Lung Dis 2003; 7: 165-171. (Pubitemid 36172678)
15. World Health Organization. Generic protocols for cost and cost-effectiveness analysis of tuberculosis diagnosis and treatment services. Geneva, Switzerland: WHO, 1999: p 166.
16. Drummond M, Sculpher M J, Torrance G W, O'Brien B J, Stoddart G L. Methods for the economic evaluation of health care programmes. Oxford, UK: Oxford Medical Publications, Oxford University Press, 2005.
17. Gold M R S J, Russell L B, Weinstein M C, eds. Cost-effectiveness in health and medicine. New York, NY, USA: Oxford University Press, 1996.
18. Lönnroth K, Uplekar M, Blanc L. Hard gains through soft contracts: productive engagement of private providers in tuberculosis control. Bull World Health Organ 2006; 84: 876-883. (Pubitemid 44714423)
19. Okello D, Floyd K, Adatu F, Odeke R, Gargioni G. Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S72-S79. (Pubitemid 37162934)
20. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F. Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S29-S37. (Pubitemid 37162929)
21. Nganda B, Wang'ombe J, Floyd K, Kangangi J. Cost and cost- effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 2003; 7 (Suppl 1): S14-S20. (Pubitemid 37162927)
22. Khan M A, Walley J D, Witter S N, Imran A, Safdar N. Costs and cost-effectiveness of different DOT strategies for the treatment of tuberculosis in Pakistan. Health Policy Plann 2002; 17: 178-186. (Pubitemid 34587121)
23. Rajeswari R, Balasubramanian R, Muniyandi M, Geetharamani S, Thresa X, Venkatesan P. Socio-economic impact of tuberculosis on patients and family in India. Int J Tuberc Lung Dis 1999; 3: 869-877.